Also, the combination of docetaxel and either IL10 or IL-24 could significantly increase the number of apoptotic cells, with p-values of 0.001 and 0.024 in LNCaP cells, and p-values of 0.007 and 0.005 in PC-3 cells, respectively, indicating a chemo-sensitizing role of IL-10 and IL-24 in docetaxel treatment in prostate cancer cells. This evidence concerns the gene IL24 and prostate carcinoma.